TBCRC 022: Phase II trial of neratinib + capecitabine for patients (Pts) with human epidermal growth factor receptor 2 (HER2+) breast cancer brain metastases (BCBM).
暂无分享，去创建一个
E. Winer | Minetta C. Liu | R. Gelman | K. Blackwell | A. Wolff | N. Tung | C. Anders | B. Moy | M. Melisko | S. Puhalla | I. Krop | R. Connolly | C. Poznak | R. Freedman | P. Niravath | S. Farooq | J. Nangia | N. Lin | Christine M. Cotter | Anne Cropp